{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T21:47:09Z","timestamp":1772488029280,"version":"3.50.1"},"reference-count":21,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T00:00:00Z","timestamp":1659225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2017ZX10201101002-004"],"award-info":[{"award-number":["2017ZX10201101002-004"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["11971479"],"award-info":[{"award-number":["11971479"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2017ZX10201101002-004"],"award-info":[{"award-number":["2017ZX10201101002-004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["11971479"],"award-info":[{"award-number":["11971479"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>To study the characteristics of HIV pretreatment drug resistance (PDR) and acquired drug resistance (ADR) in Hefei, a cross-sectional survey was used to collect 816 samples from newly reported HIV infections from 2017 to 2020 and 127 samples from HIV infections with virological failure from 2018 to 2019 in Hefei. HIV drug resistance levels and drug resistance mutations were interpreted using the Stanford Drug Resistance Database. Molecular networks were constructed by HIV-TRACE. Among the newly reported infections in Hefei, the prevalence of PDR was 6.4% (52\/816). The drug resistance mutations were mainly V179E\/D\/T (12.4%), K103N (1.3%), and V106I\/M (1.3%). In addition, it was found that the CRF55_01B subtype had a higher drug resistance rate than other subtypes (p &lt; 0.05). Molecular network analysis found that K103N and V179E may be transmitted in the cluster of the CRF55_01B subtype. The prevalence of ADR among HIV infections with virological failure was 38.6% (49\/127), and the drug resistance mutations were mainly M184V (24.4%), K103N\/S (15.7%), Y181C (11.0%), G190S\/A\/E (10.2%), and V106M\/I (10.2%). The molecular network was constructed by combining HIV infections with virological failure and newly reported infections; M184V and Y181C may be transmitted between them. The chi-square trend test results indicated that the higher the viral load level, the greater the number of newly reported infections linked to the infections with virological failure in the molecular network. In conclusion, interventions should focus on infections of the CRF55_01B subtype to reduce the transmission of drug-resistant strains. However, improving the treatment effect of HIV infections is beneficial for reducing the second-generation transmission of HIV.<\/jats:p>","DOI":"10.3390\/pathogens11080866","type":"journal-article","created":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T04:04:00Z","timestamp":1659326640000},"page":"866","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Epidemic Characteristics of HIV Drug Resistance in Hefei, Anhui Province"],"prefix":"10.3390","volume":"11","author":[{"given":"Shan","family":"Zheng","sequence":"first","affiliation":[{"name":"State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS\/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjun","family":"Wu","sequence":"additional","affiliation":[{"name":"Anhui Provincial Center for Disease Control and Prevention, Hefei 230601, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Hao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS\/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS\/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongwang","family":"Hu","sequence":"additional","affiliation":[{"name":"Hefei Center for Disease Control and Prevention, Hefei 230061, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS\/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Song","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS\/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS\/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhua","family":"Lei","sequence":"additional","affiliation":[{"name":"Hefei Center for Disease Control and Prevention, Hefei 230061, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Wang","sequence":"additional","affiliation":[{"name":"Hefei Center for Disease Control and Prevention, Hefei 230061, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingjie","family":"Liao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS\/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Feng","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS\/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Shao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS\/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhua","family":"Ruan","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS\/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Xing","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS\/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,31]]},"reference":[{"key":"ref_1","unstructured":"UNAIDS (2021, November 29). UNAIDS Data 2021. Available online: https:\/\/www.unaids.org\/en\/resources\/documents\/2021\/2021_unaids_data."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"vex008","DOI":"10.1093\/ve\/vex008","article-title":"Transmission fitness of drug-resistant HIV revealed in a surveillance system transmission network","volume":"3","author":"Wertheim","year":"2017","journal-title":"Virus Evol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Xu, X., Luo, L., Song, C., Li, J., Chen, H., Zhu, Q., Lan, G., Liang, S., Shen, Z., and Cao, Z. (2021). Survey of pretreatment HIV drug resistance and the genetic transmission networks among HIV-positive individuals in southwestern China, 2014\u20132020. BMC Infect. Dis., 21.","DOI":"10.1186\/s12879-021-06847-5"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/QAD.0000000000002812","article-title":"Using longitudinal genetic-network study to understand HIV treatment-as-prevention","volume":"35","author":"Kang","year":"2021","journal-title":"AIDS"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12985-020-1281-y","article-title":"Genetic characterization of HIV-1 epidemic in Anhui Province, China","volume":"17","author":"Zhang","year":"2020","journal-title":"Virol. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/0956462415580886","article-title":"Prevalence and associated factors of HIV infection among men who have sex with men in Hefei, China, 2013\u20132014: A cross-sectional study","volume":"27","author":"Liu","year":"2015","journal-title":"Int. J. STD AIDS"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Nelson, L.E., Nyblade, L., Torpey, K., Logie, C.H., Qian, H.-Z., Manu, A., Gyamerah, E., Boakye, F., Appiah, P., and Turner, D. (2021). Multi-level intersectional stigma reduction intervention to increase HIV testing among men who have sex with men in Ghana: Protocol for a cluster randomized controlled trial. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0259324"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1007\/s10461-021-03262-4","article-title":"Stigma, HIV Risk, and Access to HIV Prevention and Treatment Services Among Men Who have Sex with Men (MSM) in the United States: A Scoping Review","volume":"25","author":"Babel","year":"2021","journal-title":"AIDS Behav."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/22221751.2021.1884004","article-title":"The prevalence of CRF55_01B among HIV-1 strain and its connection with traffic development in China","volume":"10","author":"Gan","year":"2021","journal-title":"Emerg. Microbes Infect."},{"key":"ref_10","first-page":"333","article-title":"Study of HIV-1 subtype diversity and drug resistance among antiretroviral treatment-naive patients in Hefei district","volume":"19","author":"Qian","year":"2013","journal-title":"Anhui J. Prev. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.46234\/ccdcw2021.251","article-title":"Changing Proportions of HIV-1 Subtypes and Transmitted Drug Resistance Among Newly Diagnosed HIV\/AIDS Individuals\u2014China, 2015 and 2018","volume":"3","author":"Hao","year":"2021","journal-title":"China CDC Wkly."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1017\/S095026882000093X","article-title":"The characteristics of pretreatment HIV-1 drug resistance in western Yunnan, China","volume":"148","author":"Chen","year":"2020","journal-title":"Epidemiol. Infect."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1089\/aid.2020.0056","article-title":"HIV-1 Genetic Diversity and High Prevalence of Pretreatment Drug Resistance in Tianjin, China","volume":"36","author":"Zeng","year":"2020","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"104098","DOI":"10.1016\/j.meegid.2019.104098","article-title":"Natural presence of V179E and rising prevalence of E138G in HIV-1 reverse transcriptase in CRF55_01B viruses","volume":"77","author":"Liu","year":"2019","journal-title":"Infect. Genet. Evol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"100238","DOI":"10.1016\/j.eclinm.2019.100238","article-title":"Trend of HIV-1 drug resistance in China: A systematic review and meta-analysis of data accumulated over 17 years (2001\u20132017)","volume":"18","author":"Zuo","year":"2020","journal-title":"eClinicalMedicine"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1097\/QAD.0000000000000811","article-title":"Assessing transmissibility of HIV-1 drug resistance mutations from treated and from drug-naive individuals","volume":"29","author":"Winand","year":"2015","journal-title":"AIDS"},{"key":"ref_17","first-page":"53","article-title":"The Prevalence of Transmitted Antiretroviral Drug Resistance in Treatment-Naive HIV-Infected Individuals in China: China Meets New AIDS Challenges","volume":"2010","author":"LIAO","year":"1999","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_18","unstructured":"World Health Organization (2014, May 16). Surveillance of HIV Drug Resistance in Populations Initiating Antiretroviral Therapy (Pre-Treatment HIV Drug Resistance): Concept Note. Available online: https:\/\/apps.who.int\/iris\/handle\/10665\/112802."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1093\/molbev\/msy016","article-title":"HIV-TRACE (TRAnsmission Cluster Engine): A Tool for Large Scale Molecular Epidemiology of HIV-1 and Other Rapidly Evolving Pathogens","volume":"35","author":"Weaver","year":"2018","journal-title":"Mol. Biol. Evol."},{"key":"ref_20","first-page":"512","article-title":"Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees","volume":"10","author":"Tamura","year":"1993","journal-title":"Mol. Biol. Evol."},{"key":"ref_21","unstructured":"(2020, January 01). PS18-1802 Attachments | Announcements | Funding | HIV\/AIDS | CDC, Available online: https:\/\/www.cdc.gov\/hiv\/funding\/announcements\/ps18-1802\/attachments.html."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/11\/8\/866\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:13Z","timestamp":1760140813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/11\/8\/866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,31]]},"references-count":21,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["pathogens11080866"],"URL":"https:\/\/doi.org\/10.3390\/pathogens11080866","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,31]]}}}